Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Стадирование опухолевого процесса и формирование групп риска у детей, больных герминогенными опухолями яичников
Стадирование опухолевого процесса и формирование групп риска у детей, больных герминогенными опухолями яичников
Нечушкина И.В., Нечушкина В.М., Бойченко Е.И. и др. Стадирование опухолевого процесса и формирование групп риска у детей, больных герминогенными опухолями яичников. Современная Онкология. 2019; 21 (1): 36–39. DOI: 10.26442/18151434.2019.1.190251
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
В обзоре литературы представлены данные о стадировании герминогенных опухолей яичников у детей, а также формировании групп риска. Определение стадии процесса и формирование групп риска значительно отличаются от принятых во взрослой онкологии.
Ключевые слова: герминогенные опухоли, опухоли яичников, детская онкология.
Key words: germ cell tumors, ovarian tumors, pediatric oncology.
Ключевые слова: герминогенные опухоли, опухоли яичников, детская онкология.
________________________________________________
Key words: germ cell tumors, ovarian tumors, pediatric oncology.
Полный текст
Список литературы
1. Palenzuela G, Martin E, Meunier A et al. Comprehensive staging allows for excellent out-come in patients with localized malignant germ cell tumor ovary. Ann Surg 2008; 248: 836–41.
2. Liu Q, Ding X, Yang J et al. The signification of comprehensive staging surgery in malignant ovarian germ cell tumors. Gynecol Oncol 2013; 131 (3): 551–4.
3. Billmire DF, Cullen JW, Frederick JR et al. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Chidren’s Oncology Group. J Clin Oncol 2014; 32 (5): 465–70.
4. Billmire D, Vinocur C, Rescorla F et al. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg 2004; 39 (3): 424–9.
5. Kurman RJ, Norris HJ. Endodermal sinus tumor of ovary. A clinical and pathologic analysis of 71 cases. Cancer 1976; 38 (6): 2404–19.
6. Cushing B, Giller R, Cullen JW et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study – Pediatric Oncology Group 9049 and Children Cancer Group 8882. J Clin Oncol 2004; 22: 2691–700.
7. Palenzuela G, Martin E, Meunier A et al. Comprehensive staging allows for excellent out-come in patients with localized malignant germ cell tumor ovary. Ann Surg 2008; 248: 836–41.
8. Буланов А.А., Трякин А.А., Тюляндин С.А. Лечение герминогенных опухолей ранних (I, IIA, B) стадий. Практическая онкология. 2006; 7 (1): 24–9.
[Bulanov A.A., Triakin A.A., Tiuliandin S.A. Lechenie germinogennykh opukholei rannikh (I, IIA, B) stadii. Prakticheskaia onkologiia. 2006; 7 (1): 24–9 (in Russian).]
9. Тюляндин С.А. Герминогенные опухоли яичников. Практическая онкология. 2006; 7 (1): 52–61.
[Tiuliandin S.A. Germinogennye opukholi iaichnikov. Prakticheskaia onkologiia. 2006; 7 (1): 52–61 (in Russian).]
10. Oltmann SC, Garcia NM, Barber R et al. Pediatric ovarian malignancies: how efficacious are current staging practices? J Pediatr Surg 2010; 45 (6): 1096–102.
11. Frazier AL, Rumcheva P, Olson T et al. Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2008; 50 (4): 746–51.
12. Lee KH, Lee IH, Kim BG et al. Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women; A Korean Gynecologic Oncology Group Study. Int J Gynecol Cancer 2009; 19 (1): 84–7.
13. Zanagnolo V, Sartori E, Galleri G et al. Clinical review of 55 cases of malignant ovarian germ cell tumors. Eur J Gynaecol Oncol 2004;
25 (3): 315–20.
14. Panteli C, Curry J, Kiely E et al. Ovarian germ cell tumors: a 17-year study in a single unit. Eur J Pediatr Surg 2009; 19: 96–100.
2. Liu Q, Ding X, Yang J et al. The signification of comprehensive staging surgery in malignant ovarian germ cell tumors. Gynecol Oncol 2013; 131 (3): 551–4.
3. Billmire DF, Cullen JW, Frederick JR et al. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Chidren’s Oncology Group. J Clin Oncol 2014; 32 (5): 465–70.
4. Billmire D, Vinocur C, Rescorla F et al. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg 2004; 39 (3): 424–9.
5. Kurman RJ, Norris HJ. Endodermal sinus tumor of ovary. A clinical and pathologic analysis of 71 cases. Cancer 1976; 38 (6): 2404–19.
6. Cushing B, Giller R, Cullen JW et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study – Pediatric Oncology Group 9049 and Children Cancer Group 8882. J Clin Oncol 2004; 22: 2691–700.
7. Palenzuela G, Martin E, Meunier A et al. Comprehensive staging allows for excellent out-come in patients with localized malignant germ cell tumor ovary. Ann Surg 2008; 248: 836–41.
8. Bulanov A.A., Triakin A.A., Tiuliandin S.A. Lechenie germinogennykh opukholei rannikh (I, IIA, B) stadii. Prakticheskaia onkologiia. 2006; 7 (1): 24–9 (in Russian).
9. Tiuliandin S.A. Germinogennye opukholi iaichnikov. Prakticheskaia onkologiia. 2006; 7 (1): 52–61 (in Russian).
10. Oltmann SC, Garcia NM, Barber R et al. Pediatric ovarian malignancies: how efficacious are current staging practices? J Pediatr Surg 2010; 45 (6): 1096–102.
11. Frazier AL, Rumcheva P, Olson T et al. Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2008; 50 (4): 746–51.
12. Lee KH, Lee IH, Kim BG et al. Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women; A Korean Gynecologic Oncology Group Study. Int J Gynecol Cancer 2009; 19 (1): 84–7.
13. Zanagnolo V, Sartori E, Galleri G et al. Clinical review of 55 cases of malignant ovarian germ cell tumors. Eur J Gynaecol Oncol 2004;
25 (3): 315–20.
14. Panteli C, Curry J, Kiely E et al. Ovarian germ cell tumors: a 17-year study in a single unit. Eur J Pediatr Surg 2009; 19: 96–100.
2. Liu Q, Ding X, Yang J et al. The signification of comprehensive staging surgery in malignant ovarian germ cell tumors. Gynecol Oncol 2013; 131 (3): 551–4.
3. Billmire DF, Cullen JW, Frederick JR et al. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Chidren’s Oncology Group. J Clin Oncol 2014; 32 (5): 465–70.
4. Billmire D, Vinocur C, Rescorla F et al. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg 2004; 39 (3): 424–9.
5. Kurman RJ, Norris HJ. Endodermal sinus tumor of ovary. A clinical and pathologic analysis of 71 cases. Cancer 1976; 38 (6): 2404–19.
6. Cushing B, Giller R, Cullen JW et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study – Pediatric Oncology Group 9049 and Children Cancer Group 8882. J Clin Oncol 2004; 22: 2691–700.
7. Palenzuela G, Martin E, Meunier A et al. Comprehensive staging allows for excellent out-come in patients with localized malignant germ cell tumor ovary. Ann Surg 2008; 248: 836–41.
8. Буланов А.А., Трякин А.А., Тюляндин С.А. Лечение герминогенных опухолей ранних (I, IIA, B) стадий. Практическая онкология. 2006; 7 (1): 24–9.
[Bulanov A.A., Triakin A.A., Tiuliandin S.A. Lechenie germinogennykh opukholei rannikh (I, IIA, B) stadii. Prakticheskaia onkologiia. 2006; 7 (1): 24–9 (in Russian).]
9. Тюляндин С.А. Герминогенные опухоли яичников. Практическая онкология. 2006; 7 (1): 52–61.
[Tiuliandin S.A. Germinogennye opukholi iaichnikov. Prakticheskaia onkologiia. 2006; 7 (1): 52–61 (in Russian).]
10. Oltmann SC, Garcia NM, Barber R et al. Pediatric ovarian malignancies: how efficacious are current staging practices? J Pediatr Surg 2010; 45 (6): 1096–102.
11. Frazier AL, Rumcheva P, Olson T et al. Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2008; 50 (4): 746–51.
12. Lee KH, Lee IH, Kim BG et al. Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women; A Korean Gynecologic Oncology Group Study. Int J Gynecol Cancer 2009; 19 (1): 84–7.
13. Zanagnolo V, Sartori E, Galleri G et al. Clinical review of 55 cases of malignant ovarian germ cell tumors. Eur J Gynaecol Oncol 2004;
25 (3): 315–20.
14. Panteli C, Curry J, Kiely E et al. Ovarian germ cell tumors: a 17-year study in a single unit. Eur J Pediatr Surg 2009; 19: 96–100.
________________________________________________
2. Liu Q, Ding X, Yang J et al. The signification of comprehensive staging surgery in malignant ovarian germ cell tumors. Gynecol Oncol 2013; 131 (3): 551–4.
3. Billmire DF, Cullen JW, Frederick JR et al. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Chidren’s Oncology Group. J Clin Oncol 2014; 32 (5): 465–70.
4. Billmire D, Vinocur C, Rescorla F et al. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg 2004; 39 (3): 424–9.
5. Kurman RJ, Norris HJ. Endodermal sinus tumor of ovary. A clinical and pathologic analysis of 71 cases. Cancer 1976; 38 (6): 2404–19.
6. Cushing B, Giller R, Cullen JW et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study – Pediatric Oncology Group 9049 and Children Cancer Group 8882. J Clin Oncol 2004; 22: 2691–700.
7. Palenzuela G, Martin E, Meunier A et al. Comprehensive staging allows for excellent out-come in patients with localized malignant germ cell tumor ovary. Ann Surg 2008; 248: 836–41.
8. Bulanov A.A., Triakin A.A., Tiuliandin S.A. Lechenie germinogennykh opukholei rannikh (I, IIA, B) stadii. Prakticheskaia onkologiia. 2006; 7 (1): 24–9 (in Russian).
9. Tiuliandin S.A. Germinogennye opukholi iaichnikov. Prakticheskaia onkologiia. 2006; 7 (1): 52–61 (in Russian).
10. Oltmann SC, Garcia NM, Barber R et al. Pediatric ovarian malignancies: how efficacious are current staging practices? J Pediatr Surg 2010; 45 (6): 1096–102.
11. Frazier AL, Rumcheva P, Olson T et al. Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2008; 50 (4): 746–51.
12. Lee KH, Lee IH, Kim BG et al. Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women; A Korean Gynecologic Oncology Group Study. Int J Gynecol Cancer 2009; 19 (1): 84–7.
13. Zanagnolo V, Sartori E, Galleri G et al. Clinical review of 55 cases of malignant ovarian germ cell tumors. Eur J Gynaecol Oncol 2004;
25 (3): 315–20.
14. Panteli C, Curry J, Kiely E et al. Ovarian germ cell tumors: a 17-year study in a single unit. Eur J Pediatr Surg 2009; 19: 96–100.
Авторы
И.В.Нечушкина*1,2, В.М.Нечушкина1,3, Е.И.Бойченко1,2, Н.А.Сусулева1,2, А.П.Казанцев1, П.А.Керимов1, М.И.Нечушкин1, М.А.Рубанский1
1 ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н.Блохина» Минздрава России. 115478, Россия, Москва, Каширское ш., д. 23;
2 ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России. 125993, Россия, Москва, ул. Баррикадная, д. 2;
3 ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1
*ivnechushkina@mail.ru
1 N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation. 23, Kashirskoe h., Moscow, 115478, Russian Federation;
2 Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation. 2/1, Barrikadnaia st., Moscow, 125993, Russian Federation;
3 N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 1, Ostrovitianova st., Moscow, 117997, Russian Federation
*ivnechushkina@mail.ru
1 ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н.Блохина» Минздрава России. 115478, Россия, Москва, Каширское ш., д. 23;
2 ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России. 125993, Россия, Москва, ул. Баррикадная, д. 2;
3 ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1
*ivnechushkina@mail.ru
________________________________________________
1 N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation. 23, Kashirskoe h., Moscow, 115478, Russian Federation;
2 Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation. 2/1, Barrikadnaia st., Moscow, 125993, Russian Federation;
3 N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 1, Ostrovitianova st., Moscow, 117997, Russian Federation
*ivnechushkina@mail.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.